Compare Snowflake Inc (SNOW) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snowflake Inc vs Stryker Corporation — how do they compare? Snowflake Inc trades at $368.89 (market cap $121.15B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Snowflake Inc and Stryker Corporation are close in size by market cap, and Stryker Corporation pays a 1.27% dividend while Snowflake Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Snowflake Inc for 54 Days and Stryker Corporation for 21 Days on average.
| SNOW | SYK | |
|---|---|---|
Market Cap | $121.15B | $106.24B |
Volume | 3,986,549 | 2,982,001 |
Sector | Technology | Health |
52-Week High | $356.47 | $388.35 |
52-Week Low | $121.11 | $269.75 |
Typical Hold Time | 54 Days | 21 Days |
Enterprise Value | $121.57B | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Snowflake (SNOW) trades at $343.40, up 3.17% with strong technical momentum and bullish moving average signals. The company shows impressive revenue growth from $1.2B in 2022 to $3.63B in 2025, though it remains unprofitable with a -20.07% net margin. Recent earnings beats and a $3.75B convertible note offering highlight strategic positioning in the AI data cloud market. Analyst consensus is strongly bullish with 81% buy ratings and a $418 price target, representing 22% upside potential.
Snowflake presents a growth-over-profits investment case with expanding revenue and market leadership in data cloud services. Key opportunities include AI integration partnerships and enterprise adoption, while risks center on persistent losses, high valuation multiples (P/S 21.75), and competitive pressure from cloud giants. The stock's technical strength and Wall Street optimism suggest continued upside if execution matches growth expectations.
Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.
Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
